Literature DB >> 15861873

An investigation into the source and spread of foot and mouth disease virus from a wildlife conservancy in Zimbabwe.

S K Hargreaves1, C M Foggin, E C Anderson, A D S Bastos, G R Thomson, N P Ferris, N J Knowles.   

Abstract

African buffalo were introduced into a wildlife conservancy in the southeast of Zimbabwe in an effortto increase the conservancy's economic viability, which is primarily based on eco-tourism. The buffalo were infected with SAT serotypes (SAT-1, SAT-2 and SAT-3) of foot and mouth disease (FMD) virus, and in order to isolate the conservancy and prevent the transmission of FMD to adjacent populations of domestic livestock, the conservancy was surrounded by a double-fence system, 1.8 m in height. The intention was to prevent the movement of both wildlife and domestic animals across the perimeter. However, two years after the buffalo were introduced, FMD occurred in cattle farmed just outside of the conservancy. Using serological and molecular diagnostic tests, epidemiological investigations showed that it was most likely that antelope (impala or kudu), infected through contact with the buffalo herd within the conservancy, had jumped over the fence and transmitted the virus to the cattle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15861873     DOI: 10.20506/rst.23.3.1519

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  8 in total

1.  Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease.

Authors:  Julie Perkins; Satya Parida; Alfonso Clavijo
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

2.  The role of African buffalos (Syncerus caffer) in the maintenance of foot-and-mouth disease in Uganda.

Authors:  Chrisostom Ayebazibwe; Frank N Mwiine; Kirsten Tjørnehøj; Sheila N Balinda; Vincent B Muwanika; Anna R Ademun Okurut; Graham J Belsham; Preben Normann; Hans R Siegismund; Soren Alexandersen
Journal:  BMC Vet Res       Date:  2010-12-11       Impact factor: 2.741

Review 3.  Evaluating the potential for the environmentally sustainable control of foot and mouth disease in Sub-Saharan Africa.

Authors:  Kenneth J Ferguson; Sarah Cleaveland; Daniel Thomas Haydon; Alexandre Caron; Richard A Kock; Tiziana Lembo; J Grant C Hopcraft; Bertrand Chardonnet; Thomas Nyariki; Julius Keyyu; David James Paton; Fredrick Mathias Kivaria
Journal:  Ecohealth       Date:  2013-09       Impact factor: 3.184

Review 4.  Challenges and economic implications in the control of foot and mouth disease in sub-saharan Africa: lessons from the zambian experience.

Authors:  Y Sinkala; M Simuunza; D U Pfeiffer; H M Munang'andu; M Mulumba; C J Kasanga; J B Muma; A S Mweene
Journal:  Vet Med Int       Date:  2014-08-21

5.  Relationship between burden of infection in ungulate populations and wildlife/livestock interfaces.

Authors:  A Caron; E Miguel; C Gomo; P Makaya; D M Pfukenyi; C Foggin; T Hove; M de Garine-Wichatitsky
Journal:  Epidemiol Infect       Date:  2013-02-26       Impact factor: 4.434

6.  Transmission of Foot-and-Mouth Disease SAT2 Viruses at the Wildlife-Livestock Interface of Two Major Transfrontier Conservation Areas in Southern Africa.

Authors:  Barbara P Brito; Ferran Jori; Rahana Dwarka; Francois F Maree; Livio Heath; Andres M Perez
Journal:  Front Microbiol       Date:  2016-04-22       Impact factor: 5.640

7.  Seroprevalence of Foot-and-Mouth Disease in Susceptible Wildlife in Israel.

Authors:  Ehud Elnekave; Roni King; Kees van Maanen; Hila Shilo; Boris Gelman; Nick Storm; Eyal Klement
Journal:  Front Vet Sci       Date:  2016-04-25

8.  Serological profile of foot-and-mouth disease in wildlife populations of West and Central Africa with special reference to Syncerus caffer subspecies.

Authors:  Antonello Di Nardo; Geneviève Libeau; Bertrand Chardonnet; Philippe Chardonnet; Richard A Kock; Krupali Parekh; Pip Hamblin; Yanmin Li; Satya Parida; Keith J Sumption
Journal:  Vet Res       Date:  2015-07-08       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.